COVID-19 Pandemic, Psychiatric Disorder
Conditions
Keywords
covid-19, psychiatry
Brief summary
Research Hypothesis: Living conditions during COVID-19, and lockdowns and curfews impact the psychological state of patients (assessed by the degree of depression, positive and negative thoughts, insomnia, state of post-traumatic stress).
Detailed description
From the early stages of the COVID-19 pandemic, concerns were raised about its effect on mental health and on patients with mental illness. Several surveys and cross-sectional assessments, in Italy, England, Ecuador and China in 2020, have suggested that patients with COVID-19 have symptoms of anxiety (including stress disorder traumatic, depression and insomnia. In France, a survey by Santé Publique France on the impact of COVID-19 on mental health carried out in November 2020, revealed a 20% rate of depressive symptoms in the general population. The objective of this study is to assess the level of psychological distress and the prevalence of psychiatric disorders related to COVID-19 as part of the follow-up of psychiatric patients in the department of Eure since March 2020, which has coincided with the onset of the health crisis, including consecutive lockdowns and curfews.
Interventions
OTHERQuestionnaires
Different questionnaires detailed in the objectives part
Sponsors
New Hospital of Navarre
Centre Hospitalier Eure-Seine
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* At least 18 years old * Coming for a psychiatric consultation or hospitalization at the New Hospital of Navarre or in the extra-hospital centers of the department of Eure * Patient who has received the information note and who does not refuse to participate in the study
Exclusion criteria
* Patient not understanding French * Patient followed in psychiatry for a major cognitive disorder * Patient under legal protection measure (guardianship, curatorship, safeguard of justice, future protection mandate or family authorization)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Evaluation of prevalence of severe depression in patients followed in psychiatry in the department of Eure | Baseline | The scale used is BDI-FS-Fr (Beck Depression Inventory-Fast Screen-French) scale, composed of seven self-assessment items taken from the 21 items of the BDI-II. The BDI-FS-Fr has been validated in France. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Describe population characteristics | Baseline | Typical demographic information such as age, gender, education level, current living situation, etc, and characteristics related to COVID-19 |
| Evaluation of sleep disorder | Baseline | It will be effectuated via the Insomnia Severity Index (ISI) that is a self-reported measure assessing the subjective symptoms and consequences of insomnia, as well as the degree of worry or distress caused by sleep difficulties. The French version of the ISI has also been validated. |
| Evaluation of post-traumatic stress disorder | Baseline | The evaluation of post-traumatic stress disorder is performed via the SPAN (Startle, Physiological arousal, Anger, and Numbness) scale. The SPAN is a four-item scale for post-traumatic stress disorder that was empirically derived from the DTS (Davidson Trauma Scale). The minimum value for this scale is 0, the maximum, 16. Higher scores mean a worse outcome. |
| Evaluation of positive and negative thoughts | Baseline | Both positive and negative thoughts will be assessed using two positive and negative thought screening thermometers. Scoring is calculated from 0 to 10 for each scale. |
Countries
France
Contacts
Primary ContactSorina Mihailescu, MD
Outcome results
None listed